Purpose. The pharmacology, pharmacokinetics, clinical efficacy, and safety of febuxostat are reviewed. Summary. Febuxostat is a novel non-purine selective inhibitor of xanthine oxidase for the ...

Am J Health Syst Pharm. 2011;68(5):389-398.

It’s a common ailment for those with lavish tastes—and for the convivial. But it really can strike anyone. But good news for people affected by gout, or at least those ...

Looking back over the journey from our humble beginnings in 1999, exploring the impact NICE has had so far, and the changes we're making to ensure we continue to add value to an evolving health and ...

Current first-line therapies like allopurinol and febuxostat can be very effective, but some patients – roughly 1% according to FDA estimates – don’t get the hoped-for benefit, while others ...

高尿酸血症虽然初期可能无明显症状，但其潜在的健康威胁不容忽视。通过科学合理的饮食、运动和生活习惯调整，以及必要的医疗干预，我们可以有效预防和控制高尿酸血症，保护自己和家人的健康。

These include: Aloprim (allopurinol) Uloric (febuxostat) Krystexxa (pegloticase) Benemid (probenecid) With treatment, tophi can be dissolved and will completely disappear over time. Lifestyle changes ...

Gout affects around 9 million Americans, and around 50% of those with gout will have their first attacks begin in the big toe. The severity of gout will depend on the individual, but, on average ...

医生通常会根据患者的具体情况，开具降低尿酸的药物，比如别嘌醇（Allopurinol）或非布索坦（Febuxostat）。这些药物并非速效，但长期服用可以帮助患者维持一个相对较低的尿酸水平，从而减少痛风发作的可能性。因此，痛风患者在急性期可以适当使用 ...